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Letter to the Editor
overseer or controller. The ligands are naturally dividedUnified Nomenclature
into two structural types, being membrane-anchoredfor Eph Family Receptors either by a glycosylphosphatidylinositol (GPI) linkage or
through a transmembrane domain. In addition, theseand Their Ligands, the Ephrins
two subgroups of ligands can be divided on the basis
of their sequence relationships (Figure 1) and function-The largest subfamily of receptor protein-tyrosine ki-
ally on the basis of their preferential binding to twonases consists of receptors related to Eph, a receptor
corresponding receptor subgroups, as described be-named for its expression in an erythropoietin-producing
low. For this reason, it is proposed that the ligands behuman hepatocellular carcinomacell line. This subfamily
divided into the ephrin-A subclass, which are GPI-linkedhas received considerable attention as receptors and
proteins, and the ephrin-B subclass, which are trans-their ligands have been identified at a dizzying pace
membrane proteins. The locus designations for humanin recent years and implicated in cell±cell interactions
gene map positions for these two subclasses will beinvolved in nervous system patterning, including axon
EFNA and EFNB (previously designated EPLG).guidance, and in other aspectsof development. To date,
Receptorsfourteen distinct receptors of this subfamily and eight
It is proposed that the receptors be known as Eph re-distinct ligands have been identified in warm-blooded
ceptors. The Eph family receptors can be divided intovertebrates (mammals and birds), with many related pro-
two groups based on the relatedness of their extracellu-teins identified in cold-blooded vertebrates and in inver-
lar domain sequences (Figure 1). This grouping alsotebrates.
appears to correspond to the ability of the receptors toBecause of the rapid pace of discovery of receptors
bind preferentially to the ephrin-A or ephrin-B proteins.and ligands in various species, many different names
It is therefore proposed that the group that includeshave been used to designate them, making it difficult
receptors interacting preferentially with ephrin-A pro-for the general scientific community to follow develop-
teins be called EphA (pronounced eff-A) and the groupments in this exciting field. To address this problem,
that includes receptors interacting preferentially with
representatives of over 20 laboratories involved in re-
ephrin-B proteins be called EphB (pronounced eff-B).
search on the Eph family initiated extensive discussions
Human gene map locus names are EPHA and EPHB,at the ªMolecular Biology of Axon Guidanceº workshop
respectively.held at the EMBL, Heidelberg, in September, 1996. As
Numbering
a result, a proposal was put forth to unify and to system-
Individual receptors and ligands within each subclass
atize the nomenclature for these ligands and receptors,
will be designated by an arabic numeral, assigned based
and an Eph Nomenclature Committee was elected to
on date of publication of an essentially full-length se-
refine the proposal in consultation with the community
quence. Current assignments for receptors and ligands
at large. The resulting nomenclature has now been en-
are shown in Table 1. These assignments are based on
dorsed by over 70scientists,1 many of whom contributed
sequences obtained in various warm-blooded verte-
extensively to defining the nomenclature and to prepar- brate species, because of the observation of high se-
ing this letter, as well as by the Human and Mouse Gene quence conservation across these species that allows
Nomenclature Committees. unambiguous assignment of orthologs (homologs di-
Ligands verging by speciation rather than by gene duplication).
It is proposed that the ligands be known as ephrins
(pronounced eff-rins), which can be derived as an abbre-
viation for Eph family receptor interacting proteins or
from the ancient Greek word euoros (ephoros), meaning
1The following scientists have endorsed the use of this nomencla-
ture: D. J. Anderson, M. Barbacid, L. J. Berg, A.D. Bergemann, F.
Bonhoeffer, B. BoÈ hme, A. W. Boyd, A. W. BraÈndli, M. Bronner-Fraser,
I. W. Caras, D. P. Cerretti, P. Chambon, P. Charnay, H.-J. Cheng,
T. Ciossek, I. O. Daar, S. Davis, V. M. Dixit, U. Drescher, A. Faissner,
J. G. Flanagan, F. A. Fletcher, G. M. Fox, J. Frisen, N.W. Gale,
P. Gilardi-Hebenstreit, C. S. Goodman, A. Hemmati-Brivanlou, M.
Henkemeyer, H. Hirai, N. Holder, S. J. Holland, T. Hunter, N. Ikegaki,
R. Klein, S. A. Koblar, C. E. Krull, R. Lansford, G. Lemke, R. A.
Lindberg, S. D. Lyman, P. C. Maisonpierre, C. Marcelle, G. C.
Miescher, B. Monschau, N. A. Nicola, M. A. Nieto, K. Ohta, D. D. M.
O'Leary, D. Orioli, E. B. Pasquale, T. Pawson, A. D. Reith, J. H.
Rogers, B. M. Rohrer, J.R. Sanes, T. D. Sargent, J. B. Scales, B.
Figure 1. Sequence Homology Trees for Eph Receptors andEphrinsSchindelholz, D. A. Siever, K. Strebhardt, H. Sugimura, H. Tanaka,
X. X. Tang, M. Tessier-Lavigne, A. Ullrich, D. M. Valenzuela, M. F. The ephrin-A ligands are GPI-anchored proteins, whereas the
ephrin-B ligands are transmembrane proteins. Dendrograms wereVerderame, A. Wanaka, V. M. Watt, A. A. Welcher, D. G. Wilkinson,
R. S. Winning, G. D. Yancopoulos, R. Zhou, A. Ziemiecki, S. L. produced with the Clustal program, using the extracellular domains
of the receptors or the conserved core sequences of the ligands.Zipursky.
Cell
404
Table 1. Nomenclature for the Eph Receptor and Ephrin Families
Receptors Ligands
New Name Previous Names New Name Previous Names
EphA1 Eph, Esk ephrin-A1 B61; LERK-1, EFL-1
EphA2 Eck, Myk2, Sek2 ephrin-A2 ELF-1; Cek7-L, LERK-6
EphA3 Cek4, Mek4, Hek, Tyro4; Hek4 ephrin-A3 Ehk1-L, EFL-2, LERK-3
EphA4 Sek, Sek1, Cek8, Hek8, Tyro1 ephrin-A4 LERK-4; EFL-4
EphA5 Ehk1, Bsk, Cek7, Hek7; Rek7 ephrin-A5 AL-1, RAGS; LERK-7, EFL-5
EphA6 Ehk2; Hek12
EphA7 Mdk1, Hek11, Ehk3, Ebk, Cek11
EphA8 Eek; Hek3
EphB1 Elk, Cek6, Net; Hek6 ephrin-B1 LERK-2, Elk-L, EFL-3, Cek5-L; STRA-1
EphB2 Cek5, Nuk, Erk, Qek5, Tyro5, Sek3; Hek5, Drt ephrin-B2 Htk-L, ELF-2; LERK-5, NLERK-1
EphB3 Cek10, Hek2, Mdk5, Tyro6, Sek4 ephrin-B3 NLERK-2, Elk-L3, EFL-6, ELF-3; LERK-8
EphB4 Htk, Myk1, Tyro11; Mdk2
EphB5 Cek9; Hek9
EphB6 Mep
Previous names are listed by publication date with full-length sequences shown first. Names after a semicolon indicate hypothetical orthologs
or proposals to rename a sequence that had previously been published. While we recommend using the new nomenclature, initial identification
references should be cited as appropriate.
Orthologs
Apparent orthologs in mammals and birds will be given
the same name. The species can optionally be indicated
by a small letter before the name (e.g., h-ephrin-A1 for
human, m- for mouse, etc. . . .). Assignments for fish
and amphibianproteins, which may largelycoincide with
those shown here, will be published elsewhere (details
will be available at the Eph Nomenclature web site
[http://www.eph-nomenclature.com]).
Naming New Sequences
A new member of the family is defined as a fully se-
quenced gene, cDNA, or protein that belongs to this
subfamily based on sequence homology. Please consult
the Eph Nomenclature web site prior to publication of
any new member, apparent ortholog, gene locus, or
splice variant to obtain details on how to assign an
appropriate name and number.
We recommend that this nomenclature be used in
future publications.
Eph Nomenclature Committee2,3
2The appropriate text citation for this letter in future publications is
as follows: (Eph Nomenclature Committee, 1997).
3The committee consists of: J. G. Flanagan,* N. W. Gale,² T. Hunter,³
E. B. Pasquale,§ and M. Tessier-Lavigne‖ (chair).
*Department of Cell Biology, Harvard Medical School, Boston, Mas-
sachusetts 02115.
²Regeneron Pharmaceuticals, Tarrytown, New York, 10591-6707.
³The Salk Institute, La Jolla, California, 92037.
§The Burnham Institute, La Jolla, California, 92037.
‖ Howard Hughes Medical Institute, Department of Anatomy,Univer-
sity of California, San Francisco, California, 94143-0452.
